Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
25.21
-0.40 (-1.56%)
At close: Aug 31, 2026, 4:00 PM EDT
25.21
0.00 (0.00%)
Pre-market: Sep 1, 2026, 4:28 AM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $46 → $50 | Buy | Reiterates | $46 → $50 | +98.33% | Aug 28, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $75 → $80 | Buy | Reiterates | $75 → $80 | +217.33% | Aug 25, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $77 | Buy | Maintains | $77 | +205.43% | Aug 21, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $67 → $74 | Buy | Reiterates | $67 → $74 | +193.53% | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $46 → $48 | Buy | Reiterates | $46 → $48 | +90.40% | Aug 21, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Hold Maintains $30 | Hold | Maintains | $30 | +19.00% | Aug 20, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $96 → $103 | Buy | Maintains | $96 → $103 | +308.57% | Aug 20, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $27 → $28 | Hold | Maintains | $27 → $28 | +11.07% | Aug 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.